68.50p-0.50 (-0.73%)12 Aug 2022, 16:31
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Creo Medical Group PLC Fundamentals

Company NameCreo Medical Group PLCLast Updated2022-08-12
IndustryMedical DevicesSectorHealthcare
Shares in Issue181.528 mMarket Cap£123.44 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.15EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.1049Debt Equity Ratio0.0706
Asset Equity Ratio1.3722Cash Equity Ratio0.5938
Quick Ratio2.4317Current Ratio3.10
Price To Book Value1.6961ROCE0

Creo Medical Group PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Creo Medical Group PLC Company Financials

Tangible Assets£8.60 m£3.38 m£1.30 m
Intangible Assets£27.25 m£28.53 m£865,241.00
Investments£1.73 m£500,000.000
Total Fixed Assets£39.44 m£32.99 m£2.17 m
Stocks£8.50 m£6.81 m£727,158.00
Debtors£4.46 m£4.36 m£748,330.00
Cash & Equivalents£43.53 m£45.09 m£81.05 m
Other Assets£1.85 m£587,000.00£8,400.00
Total Assets£100.61 m£92.46 m£88.26 m
Creditors within 1 year£19.74 m£18.03 m£5.06 m
Creditors after 1 year£7.55 m£11.63 m£543,892.00
Other Liabilities000
Total Liabilities£27.29 m£29.66 m£5.60 m
Net assets£73.32 m£62.81 m£82.66 m
Called up share capital£181,000.00£158,000.00£150,378.00
Share Premium£149.45 m£115.26 m£115.11 m
Profit / Loss-£30.34 m-£23.46 m-£18.62 m
Other Equity£73.32 m£62.81 m£82.66 m
Preference & Minorities000
Total Capital Employed£73.32 m£62.81 m£82.66 m
Debt Ratio£0.07£0.09£0.01
Assets / Equity1.37221.37221.3722
Cash / Equity0.59380.59380.5938
Cash Flow202120202019
Cash from operating activities-£26.01 m-£16.28 m-£11.85 m
Cashflow before financing£5.98 m-£14.95 m£37.27 m
Increase in Cash-£1.86 m-£35.92 m£36.46 m
Turnover£25.16 m£9.43 m£13,473.00
Cost of sales£13.58 m£5.39 m£8,522.00
Gross Profit£11.59 m£4.04 m£4,951.00
Operating Profit-£29.91 m-£23.48 m-£18.88 m
Pre-Tax profit-£30.34 m-£23.46 m-£18.62 m

Creo Medical Group PLC Company Background

ActivitiesCreo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. Its reportable segments being the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.
Latest Interim Date30 Sep 2021
Latest Fiscal Year End Date23 May 2022

Creo Medical Group PLC Directors

2022-08-04Mr. John BradshawNon-Executive Director,Senior Independent Non-Executive Director
2022-05-27Mr. Charles Alexander Evan SpicerNon-Executive Director,Chairman
2022-08-08Mr. Craig Jonathan GullifordExecutive Director,Chief Executive Officer
2022-08-08Mr. Richard John ReesExecutive Director,Chief Financial Officer and Company Secretary
2022-08-08Professor Christopher Paul HancockExecutive Director,Chief Technology Officer
2022-05-26Mr. David Gerard WoodsExecutive Director,Chief Commercial Officer

Creo Medical Group PLC Contact Details

Company NameCreo Medical Group PLC
AddressBeaufort Park Way, Unit 2, Creo House, Chepstow, NP16 5UH
Telephone+44 1291606005

Creo Medical Group PLC Advisors

SolicitorTaylor Wessing LLP
Phone+44 2073007000
Fax+44 2073007100
RegistrarEquiniti Limited
Phone+44 3713842030
Fax+44 3713842100
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
StockbrokerCenkos Securities
Phone+44 2073978900
Fax+44 2073978901
Nominated AdviserCenkos Securities
Phone+44 2073978900
Fax+44 2073978901